United Kingdom of Great Britain and Northern Ireland
Tuberculosis profile
Population  2013 63 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.34 (0.34–0.34) 0.54 (0.53–0.54)
Mortality (HIV+TB only) 0.012 (<0.01–0.02) 0.02 (0.01–0.03)
Prevalence  (includes HIV+TB) 11 (4.4–20) 17 (6.9–32)
Incidence  (includes HIV+TB) 8.3 (7.7–8.8) 13 (12–14)
Incidence (HIV+TB only) 0.098 (0.059–0.14) 0.15 (0.09–0.23)
Case detection, all forms (%) 89 (84–95)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.4 (1–1.7) 5.7 (3.2–9.4)
MDR-TB cases among notified pulmonary
TB cases
52 (40–66) 17 (10–29)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 2 807    
Pulmonary, clinically diagnosed 1 022    
Extrapulmonary 3 555    
       
Total new and relapse 7 384    
Previously treated, excluding relapses 508    
Total cases notified 7 892    
Among 7 384 new and relapse cases:
311 (4%) cases aged under 15 years; male:female ratio: 1.4
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 4 128 (147%) 250 (49%) 4 607
Laboratory-confirmed RR-/MDR-TB cases     86
Patients started on MDR-TB treatment     70
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 80
Previously treated cases, excluding relapse, registered in 2012 72
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 51
XDR-TB cases started on second-line treatment in 2011 0
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-03-30 Data: www.who.int/tb/data